Infusion set

Information

  • Patent Grant
  • 8287516
  • Patent Number
    8,287,516
  • Date Filed
    Monday, September 25, 2006
    17 years ago
  • Date Issued
    Tuesday, October 16, 2012
    11 years ago
Abstract
The invention relates to an infusion set for an intermittent or continuous administration of a therapeutical substance, such as insulin. The infusion set comprises an infusion part (OB) for insertion into a patient and a connector (OA) for connecting the infusion part with a medical device through a tube (7), the connector being axially displaceable relative to the infusion part. The infusion part comprises an adhesive support (1), a base part (2) with a first set of guiding means (13) and at least two retention devices (4) for locking the connector to the infusion part, a cannula extending from said base part and being in fluid communication with a cavity which is optionally covered with a membrane, the cavity is further adapted to receive a second cannula extending from the connector, which second cannula is in fluid communication with the tube.
Description
THE TECHNICAL FIELD

The invention relates to an infusion set for an intermittent or continuous administration of a therapeutical substance, such as insulin. An infusion set comprises an infusion part with a cannula to penetrate the skin of a person and a connector for connecting the infusion part with a medical device preferably a medical delivery device such as an insulin pump.


An infusion set has in its assembled form a substantially planar rear side and a relatively large width compared to its thickness, thus allowing it to lie flat on the patient's skin and thereby minimizing the discomfort of carrying the infusion set.


The infusion part is placed in the patient for a longer and not specified time period while the connector is supposed to be connected and disconnected from time to time. Hereby it is possible for the patient to disconnect from the medical device, move around and at a later point re-connect to the medical device. Further it is possible to shift between different medical devices using the same infusion part and thereby there is only need for one penetration of the skin which provides less discomfort to the patient.


PRIOR ART

U.S. Pat. No. 5,522,803 discloses an infusion set having an infusion part and a connector. The infusion part comprises a soft plastic cannula in liquid communication with a cavity for receiving a needle from a connector, two sloping guiding holes and two retention devices; and the connector comprises a cannula, two square guiding pins and two arms with a hooking part for gripping the retention device of the infusion part and operating in the main plane of the infusion part.


U.S. Pat. No. 6,572,586 discloses an infusion set for administration of a fluid to a subcutaneous layer and include a cannula housing adapted for mounting onto a patient's skin and a needle housing for connection to the cannula housing. The needle housing has a pair of flexible and a resilient band connected to the sidewalls. The resilient band is lockably engage able with the cannula housing thereby securing the housings together, and the resilient band is releasable from the cannula housing when pressing the sidewalls toward each other to deform the resilient band. A hollow needle extends out of a main body of the needle housing for delivering fluid to the cannula from a fluid source. The walls of the needle housing extend beyond a distal end of the hollow needle to prevent needle contact with contaminated surfaces an inadvertent injury.


In both of these infusion sets two arms are formed along the sides of the connector part and the movement performed to unrelease the connector from the infusion part is in both cases pressing the two arms together. Compared to these to constructions the present invention is of a more simple form and also the locking mechanism according to the invention allows for the user to actually see when the arms are unlocked, especially if the infusion part and the connector are toned in different colors.


Given that the infusion part is supposed to be connected and especially disconnected several times with the connector it is important that this operation is painless and simple to perform.


The object of the invention is to provide an infusion set with a coupling mechanism which can be connected and separated with as less discomfort to the patient as possible, and which infusion set is also easy for the patient to find out and to operate.


According to the invention there is provided an infusion set comprising an infusion part for insertion into a patient and a connector for connecting the infusion part with a medical device through a tube. The connector is axially displaceable relative to the infusion part, said infusion part comprising an adhesive support, a base part with a first set of guiding means and at least two retention devices for locking the connector to the infusion part, a cannula extending from said base part and being in fluid communication with a cavity which is optionally covered with a membrane, said cavity being further adapted to receive a second cannula extending from the connector, which second cannula is in fluid communication with the tube, a second set of guiding means adapted to fit with the first set of guiding means and at least two arms where the retention devices are extending from the upper surface of the main surface of the base part and the arms comprise means corresponding to the retention means.


The above described infusion set is easier to disconnect and will seem safer to use for the patient than previously known infusion sets. All that is needed to separate the connector from the infusion part is a slight simultaneous pressure on the two arms of the connector and the user will be able to see how the connection/disconnection between the infusion part and the connector takes place.


With the term cavity is meant the inner lumen of the cannula or the extension of the cannula.


In a preferred embodiment the connector is symmetrical both around the main plain of the connector and around the plane being perpendicular to the main plane and being parallel to the central axis, thus allowing the connector to be connected to the infusion part no matter which of the main sides is facing upwards. This results in an easier operation of the infusion set.


The arms of the connector can appropriately be provided with gripping means for getting a better grip of the connector. Examples of such gripping means could be but are not limited to rims, grooves, recesses, and a roughened surface optionally of another material than the connector itself, preferably recesses are used. This results in a safer and more comforting operation of the infusion set since the risk that the fingers slip during handling resulting in unintended movements of the infusion part and the cannula is reduced.


In one embodiment of the invention the connector has a reduced material content e.g. in the form of at least one groove, preferably at least two grooves, placed where the arms are connected to the central part of the connector comprising the second set of guiding means (8), thus allowing the arms of the connector to move perpendicular to the base part while the second set of guiding means are stationary. This makes it possible to disconnect the connector from the infusion part by lifting the arms instead of pressing them towards each other. Hereby it is achieved that connection/disconnection can be performed in a manner which at the same time reduces the stresses in the material during the operation, eases the operation of the locking mechanism and reduces the patient's unpleasantness during the connection/release of the connector.


In another embodiment retention devices are positioned on a particularly flexible part of the base part. The flexible part can be provided by choosing an appropriate material for the base part or by providing very thin parts of material between the retention parts and the center of the base part, but preferably the base part of the infusion part has at least two cuttings forming at least two flaps. The formed flexible parts are able to in an elastic manner to move out of the main plane of the infusion part. Hereby the same advantages during connection/release as described above are obtained.


In a preferred embodiment the cannula of the infusion part penetrates the adhesive support, thus stabilizing the position of the infusion part relative to the point of skin penetration to an even greater extend. Further this minimizes the risk that the cannula is accidently withdrawn from the patient.


In a preferred embodiment the adhesive support is a plaster.


In a preferred embodiment the infusion part and the connector are made from two different plastics materials, such as two different types of polypropylene.


In a preferred embodiment there is a visual difference in the toning of the connector and the base part of the infusion part. Hereby it is achieved that it is easier for the patient to see the separation line between the two units resulting in an easier operation of the locking mechanism.


In a preferred embodiment the retention devices are in form of at least two steps placed on either the infusion part or the connector and a matching carving in the other part. Preferably the step has a side with a triangular shape thus forming the step as a sloping hill. Preferably the retention devices are placed on the infusion part and the matching carvings are placed in the connector's arms.


In a preferred embodiment the tube is a flexible plastics material which preferably is connected with the rest of the connector by means of glue.


Preferably the medical delivery device is a drug delivery device such as an insulin delivery device e.g. in the form of an insulin pump.


The cannula of the connector can be a hard cannula, preferably a metal cannula such as a steel cannula. Also the cannula of the connector can be made of a plastics material and/or being blunt.


In a preferred embodiment the cannula is a soft cannula preferably a soft cannula made of a plastics material. Preferred plastics materials for the soft cannula are materials which are sufficiently flexible to bend, when the patient moves and sufficiently rigid to avoid kinking, closing off the drug supply. Further the material must be compatible with medical use i.e. irritation of the skin must be kept at a minimum, being non-toxic it must not decompose in the body, etc. Thermoplastic elastomers (TPE) are a type of material which fulfils these requirements. Examples of such useful elastomers are: polyester ethers, ECDEL, styrene based TPE, olefin based TPE, urethane based TPE, ester based TPE, amid based TPE, polyolefins and silicone rubbers. In a preferred embodiment the material is selected from the group consisting of polypropylene, C-FLEX™, mixtures of C-FLEX™ and polypropylene, LUPOLEN™ 1840H, LUPOLEN™ 3020D, PELLETHANE™ 2363-75D, PELLETHANE™ 2363-55D, TECOTHANE™ and CARBOTHANE™.


In a preferred embodiment the infusion part and the connector are made of polypropylene.


Given that the infusion part is supposed to be connected and especially disconnected several times with the connector it is important that the cannula of the connector is guided safely into the cavity of the infusion part and that the cannula in the disconnected situation is protected as much as possible. It is therefore a further object of the invention to provide an infusion set with an improved guiding mechanism and with an improved protection of the connector cannula.


In a preferred embodiment the connector cannula is extending from the central part of the connector and being placed in a withdrawn position relative to the front of the central part and at least one of the first set of guiding means comprises at least two stabilizing fins.


The above described invention provides an infusion set with an improved protection of the cannula of the connector thus allowing the connector to be connected and disconnected from the infusion part more times than in the previously known infusion sets.


A lot of patients e.g. insulin patients have to or may desire to insert an infusion device or to place a subcutaneous sensor or the like themselves. For some persons it is a troublesome process to perform the skin penetration themselves, they therefore need a device which assists them in this process thereby making the process less problematic.


The document US 2003/0225373 discloses an insertion device for inserting an infusion part or a sensor into a patient. The device comprises a housing, a coil spring, a safety device and part for angling the insertion into the patient. However the apparatus is relatively complicated to manufacture industrially and further the device has to be loaded manually by the patient by a rather complicated procedure.


WO 03/026728 A1 discloses an injector device comprising a housing, a spring, a slidable bar, a locking mechanism and a needle.


It is a further object of the invention to provide an improved insertion device which is easy to manufacture and which is suitable for being delivered in a loaded form or at least being easier to load. Especially elderly people who can have some motor problems need an insertion device which exists in a pre-loaded form.


The advantage in essentially vertical insertion is that it is easier to control the dept of the needle penetration and thereby the dept of the cannula. This is important in self-insertion of the infusion part.





In the following the invention will be described in further details with reference to the figures.



FIG. 1 shows one embodiment of an infusion set where the infusion part and the connector are unified.



FIG. 2 shows one embodiment of the infusion set where the infusion part and the connector are separated.



FIG. 3 shows the same embodiment of the separated infusion set as in FIG. 2 from a different angle.



FIG. 4 shows a second embodiment of a separated infusion set from a first angle.



FIG. 5 shows the second embodiment of the infusion set from a different angle.



FIG. 6 shows a first embodiment of an injector device separated from the infusion part.



FIG. 7 shows the first embodiment of the injector device joined with the infusion part.



FIG. 8 shows the first embodiment of the injector device joined with the infusion part.



FIG. 9 shows the first embodiment of the injector device where the pivoting member is embracing the needle.



FIG. 10 shows the first embodiment of the injector device in the loaded position.



FIG. 11 shows the first embodiment of the injector device in the loaded position from a second angle.



FIG. 12 shows a second embodiment of the injector device in a loaded and secured state.



FIG. 13 shows the second embodiment of the injector device in a ready to use state.



FIG. 14 shows the second embodiment of the injector device after insertion of the needle and before removing the injector from the infusion part.



FIG. 15 shows the second embodiment of the injector device after separating the injector from the infusion part.



FIG. 16 shows the second embodiment of the injector device after the pivoting arm has been positioned to embrace the needle.



FIG. 17 shows the second embodiment of the injector device after the pivoting arm has been positioned to embrace the needle seen from another angle.



FIG. 18 shows an infusion set placed on the skin.



FIG. 19 shows the second embodiment of the injector device together with a credit card.



FIG. 20 shows a third embodiment of the injector device.



FIG. 21A-D shows assembling of the infusion part and injector device according to the third embodiment.



FIG. 22 A-B shows the third embodiment of the injector device prepared for insertion.



FIG. 23 A-B shows the adhesive support of the infusion part hooked to the slidable member.



FIG. 24 A shows the injector device after insertion with an infusion part and FIG. 24 B shows the injector device after insertion without the infusion part.



FIG. 25 shows the third embodiment of the injector device after insertion and embracing the needle.



FIG. 26 shows a third embodiment of an infusion part placed on a mounting pad with two separate pieces of release liner.



FIGS. 35 A-E and 36 A-E show the different steps when using the injector device for injecting the infusion part.






FIGS. 1-3 illustrates an embodiment of an infusion set. The infusion set comprises an infusion part (0B) and a connector (0A). The infusion part (0B) comprises a base part (2) having a main plane which, when the infusion set is attached to a patient, is essentially parallel to the skin of the patient, and a shoulder part (2a) protecting the connector part (0A) from being released unintentionally. Said base part (2) comprises a first set of guiding means (13) which in this case has the form of two stabilizing fins. The base part further comprises two retention devices (4) extending from the upper surface of the base part in this case in form of two steps. Mounted on the inner surface of the infusion part is an adhesive support (1) which in this case is a plaster. A cannula (5) is extending from the base part (2) and is penetrating the adhesive support (1) being in fluid communication with a central cavity (3). The cannula (5) is preferably a soft cannula but could also be made of metal. The cavity (3) optionally being covered by a membrane is adapted to receive a second cannula (6) extending from the connector. In the embodiment shown in FIGS. 2-5 the second cannula (6) is extending from the central part of the connector and is placed in a retracted position relative to the front of the central part. In this embodiment the base part (2) has two cuttings (12) creating two flaps on which the retention devices (4) are mounted. The connector (0A) comprises two arms (9) having four carvings (10) adapted to fit with the retention devices (4). The connector (0A) is symmetrical around the main plane and around the plane perpendicular to the main plane and parallel to the main axis thus allowing the connector to match with the base part in two ways. The cannula (6) is in fluid communication with the tube (7) which provides the connection to a medical device such as an insulin pump. In this embodiment the central part of the connector has a second set of guiding means (8) in form of two grooves placed symmetrically around the main plane of the connector. In this embodiment the connector further has gripping means (11) in form of recesses. The gripping means 11 are optional and can be selected from the group consisting of rims, grooves, recesses or a roughened surface optionally of another material than the connector itself



FIGS. 4 and 5 show another embodiment of the invention where the connector has two grooves (14) which in this case are placed symmetrically around the main plane of the connector. However it is not necessary for the grooves to be places symmetrically around the main plane since they are not coupling with the infusion part.


Whether the infusion set is intended to be inserted manually or by an injector the infusion part (OB) and the connector (OA) are delivered to the user as two separate units in sterile packages. When inserted manually the infusion part (OB) will at delivery be combined with a needle unit with the same locking and guiding means (8) as the connector. The needle unit is provided with an insertion needle extending from the central front which insertion needle at delivery extends through and beyond the end of the cannula (5). The needle unit's only function will be to penetrate the user's skin where after the needle unit is removed and replaced with the connector (0A) leaving the cannula (5) subcutaneous.


The connector (0A) can be connected to a luer coupling member through the tube (7). Through the luer coupling it is possible to administer a suitable therapeutical substance, such as insulin from a pump. The connector can also be a sort of closing part with a suitable entrance for an inserting needle of a syringe. Such a closing part can stay in position for up till three days while the user can have medication, e.g. insulin injected through the entrance in order to reduce trauma to the skin caused by repeated penetration of the skin.


It is important for the user that it is easy to change i.e. to engage and to disengage the infusion part (0B) and the connector (0A) even when the user has reduced dexterity. The present invention complies with this purpose as the movement used to unlock the infusion part (OB) from the connector (OA) is pressing the connector between the first finger and the thumb which is simple and easily performed movement. Also the oppositely directed forces from respectively the first finger and the thumb pushing toward each other, are not only used to unlock the device but is also used when pulling the connector away from the infusion part (OB). In order to make it easier to disengage the connector (OA) the arms (9) can be made very flexible, either by choosing a soft and flexible material or by making the fastening of the arms (9) to the central part more or less rigid e.g. by varying the size of the grooves (14) on the shoulder of the connector (0A).


Although the arms (9) are very flexible the danger of accidently pulling the connector away from the infusion part when positioned on the skin of the user is quite small as the device has to be exposed to a simultaneous pressure from both sides.


Another advantage of the invention according to the present invention is that only a very small amount of material need to be used when producing the infusion part. The infusion part (0B) can be reduced to:

    • a slim central part comprising the cannula (5), the cavity (3) and guiding means (13),
    • a shoulder part (2a) connected to the central part and protecting the ends of the movable arms (9) of the connector when the connector is engaged with the infusion part, and
    • a base part (2) which has been reduced to two arms connected to the central part which arms are provided with the retention means (4).



FIGS. 6-11 shows a first embodiment of an injector device (29) which can be used for injection of the infusion part (0B) of the infusion set. In FIG. 6 the injector device is separated from the infusion part (0B) and FIGS. 7 and 8 show the same injector device (29) joined with an infusion part (0B). The injector device comprises a housing (30) with two longitudinally extending guiding means (31) formed as grooves in this embodiment and a longitudinally slidable member (32) having guiding means (31a), in this embodiment a rim, corresponding to the guiding means (31). A penetrating needle (35) is extending from the front part of the slidable member (32), and the needle (35) is at the end where it is fastened to the slidable member (32) surrounded by guiding means corresponding to the guiding means (13) on the infusion part (0B). The slidable member (32) is capable of moving from a retracted position to a forward position, and is driven from the retracted position to the forward position by a spring (34). The spring is located between the slidable member (32) and the back (33) of the housing. Optionally there is a spring support (37) (FIG. 8) which fits with the back of the housing thereby minimizing the risk of a malfunctioning spring. The injector device further comprises locking means (38) for maintaining the spring in a compressed state and release means (39) for disengaging the locking means. When the locking means (38) are disengaged, the spring (34) drives the slidable member (32) to its forward position, thus introducing the cannula positioned at the front end of the infusion part (0B) into the patient by means of the needle (35). After the introduction of the cannula, the injector device including the insertion needle (35) is withdrawn from the infusion part (0B) leaving the insertion needle in an exposed position. The pivoting member (36) can then be swung into a position where it embraces the needle (35) as shown in FIG. 9.



FIG. 10 and FIG. 11 show the same embodiment of the injector device in a loaded and secured position. Part of the pivoting member (36) acts as locking means (38). In FIG. 10 it can be seen how the needle (35) fits into the cannula (5) of the infusion part. The needle (35) will bring the cannula (5) with it during the skin penetration. After penetrating the skin the needle (35) secured to the injector will be withdrawn leaving the cannula inserted in the patient. In FIG. 11 the locking means are shown said locking means are disengaged when the tab (38) is pushed over the edge of the outer side of the back (33) of the housing.



FIGS. 12 to 17 show a second embodiment of the injector device according to the invention where the pivoting member (36) is fastened centrally in relation to the slidable member (32). FIG. 12 shows the injector device in a state where the pivoting member (36) protects the needle prior to injection of the cannula (5) of the infusion part (OB). The figure shows the housing (30) with another type of longitudinally extending guiding means (31), in this case a bar. The housing further has gripping means (40), preferably in the form of recesses, as means for getting a better grip of the injector device.


Centrally positioned release means (39) is shown on one of the main faces of the injector device. The advantage of a one button release mechanism is that the risk of a slanting injection is reduced.


In FIG. 13 is shown an injector device prepared for insertion of the needle. The pivoting member is positioned away from the embracing position in an angle v<<90° in relation to the main axis of the injector device where the main axis is coincident with the insertion needle. The adhesive support (1) is positioned in such manner that the cannula (5) of the infusion part (0B) and the therein positioned needle (35) penetrates the adhesive support through an opening in the release liner. When the pivoting member is positioned essentially perpendicular to the main plane of the injector device it can provide a helping mean for achieving essentially vertical injection of the needle. Further FIG. 13 shows the needle (35) of the injector device inside the cannula (5). In FIG. 14 the injector device is in a released state where the needle (35) would have penetrated the skin. The housing in the embodiment of FIG. 14 has a stopping tab (43) corresponding to a protrusion on the slidable member that keeps the slidable member (32) within the housing (30) thereby making it easier to withdraw the needle since there is no risk that the slidable member slides out of the housing. In FIG. 15 the injector device has been withdrawn, leaving the cannula (5) of the infusion part (0B) inserted in the patient. In FIGS. 16 and 17 the pivoting member (36) is in a position where it embraces the needle (35) thereby protecting the surroundings from coming into contact with the used needle (35). In FIG. 18 the infusion part (OB) has been brought from the essentially vertical insertion position to a position essentially parallel to the skin.



FIG. 19 shows the injector device together with a credit card to illustrate the size of the injector device.


In FIG. 20 is shown a third embodiment of the injector device together with an infusion part (0B). This embodiment also has a housing (30) with longitudinally extending guiding means (31) and a longitudinally slidable member (32) of a different construction compared to the two first embodiments. Also the pivoting arm (36) and the spring (34) can be seen in this figure. In this embodiment the stopping tab (43) is placed centrally and has the form of a protrusion raising form the lower side of the housing (30). The release means (39) comprises two buttons placed on each side of the housing (30).


In FIG. 21 A-D it is shown how the infusion part (0B) along with the slidable member (32) and the spring (34) of the third embodiment fit into the housing (30). The unit (?) shown between the pivoting arm (36) and the insertion part (0B) is an adapter which makes it possible to use a standard injector for different guiding means (13) on the infusion part (0B).


In FIG. 22 A-B is shown fixing means (44) placed on the pivoting member (36). It is possible to temporarily attach a part of the adhesive support (1) to the fixing means in order to secure the position of the adhesive support in such a way that the adhesive surface of the support (1) will be turned towards the skin of the patient. Further release means (39) in the form of two buttons, one on each side of the housing (30), can be seen as well as the protruding stopping tab (43).



FIG. 23 A-B shows in further details and without the housing how the adhesive support (1) is hooked to the fixing means (44) due to at least one cutting (46) in the adhesive support (1).



FIG. 24 A shows the third embodiment of the injector device with an infusion part after insertion and 24 B shows the injector device after insertion and after the injector device has been removed from the insertion part (OB).


In FIG. 25 the pivoting member (36) of the injector device is in a position embracing the needle. A locking tab (45) fixes the pivoting arm in this position. This makes certain that the needle stays embraced by the pivoting arm and thereby minimizes the risk of somebody getting hurt by the needle.



FIG. 26 illustrates a third embodiment of an infusion part (0B). The infusion part (0B) comprises a base part (2) which base part (2) comprises a first set of guiding means (13) in the form of two stabilizing fins. The base part (2) comprises two retention devices (4) extending from the upper surface of the base part (2) and having a triangular form. The side of the triangular retention device facing the shoulder part (2a) is approximately perpendicular to the surface of the base part (2) and the side facing away from the shoulder part (2a) is sloping from the top of the retention device (4) to the surface of the base part (2). Mounted on the inner surface of the infusion part (0B) is the adhesive support (1). The cannula (5) is extending from the shoulders (2a) of the base part (2) and is penetrating the adhesive support (1) being in fluid communication with the central cavity (3). The cavity (3) which can be covered by a membrane is adapted to receive a second cannula (6) extending from the connector. In this embodiment the base part (2) has two wide cuttings (12) creating two narrow flaps in the base part (2) on which the retention devices (4) are mounted.


The distance between (I) the side of the retention device (4) closest to the central part of the infusion part (OB) and (II) the central part of the infusion part (0B) defines how far it is possible to move the two arms (9) of the connector in the plane parallel to the base part (2). It is necessary for the corresponding means (10) in the arms (9) of the connector (0A) to be of less width than the distance between (I) and (II). In a preferred embodiment it would also be possible to free the connector (0A) from the infusion part (0B) by moving the arms (9) in a vertical direction away from the base part (2). If this should be possible the arms (9) of the connector need to be adequately flexible where the arms (9) are fixed to the central part of the connector. This can be done either by reducing the thickness of the arms (9) in at least on direction in this area until the desired flexibility is achieved or by choosing to construct the connector part (0A) of a material with a suitable flexibility.


In this embodiment the release liner (41, 42) of the adhesive support (1) is divided into to separated pieces. The first piece (41) is protecting the part of the adhesive support (1) in front of the cannula (5), and the second piece (42) is protecting the part of the adhesive support being behind the cannula (5) and under the infusion part. During insertion the two pieces are separated whereby the part of the adhesive in front of the cannula is bent up and the adhesive side of the adhesive support (1) is exposed around the cannula. The first piece (41) is either pulled back by the user or is attached to one side of the injector device; the second piece (42) is attached to the opposite side of the injector device.



FIGS. 35A-E and 36A-E illustrates the cycle of use of the injector device seen respectively from the upper (FIG. 35) and the lower (FIG. 36) side of the injector device.


In FIGS. 35A and 36A the device is in a first state, which is the state the device would normally be delivered to the patient in, under sterile conditions. In this state the pivoting arm (36) is in a position where it embraces the needle (35) and the angle v between the main plane of the injector device and the pivoting arm is approximately 0°, if the release means (39) should unintentionally be pressed in this situation two protruding tabs (48) will prevent the slidable member (32) from being pushed forward.


In FIGS. 35B and 36B the device is prepared for use by lifting the pivoting arm (36) backwards thereby exposing the insertion needle (35) and also in this embodiment lifting the part of the release liner (41) which is attached to the pivoting arm (36), exposing the underlying adhesive support (1). In this position the pivoting arm (36) allows for insertion of the needle and is in an angle v to main plane of the injector device where 9O°≦v≦180°, and in this position the injector device would be placed against the patient's skin.


In FIGS. 35C and 36C the release means (39) has been pressed and has released the spring (34). The spring has pushed the slidable member (32) forward until the slidable member was stopped by two stopping tabs (43). In this position the insertion needle (35) has penetrated the patient's skin and a part (this part covers an area around the needle in the full breadth of the adhesive support) of the adhesive surface of the adhesive support (1) is in contact with the patient's skin. In FIG. 36C it is shown how the second part (42) of the release liner is attached to the housing (30) and still covers the adhesive surface when the slidable member (32) is pushed forward.


In FIGS. 35D and 36D it is shown what happens when the injector device is removed from the patient, leaving the infusion part (0B) inserted subcutaneously. The user frees the first part (41) of the release liner from the pivoting arm (36) and then when pulling the injector device away the second part (42) of the release liner is also pulled away, exposing the adhesive surface of the adhesive support (1) and making it possible for the user to press the adhesive support towards the skin and thereby securing the infusion part (0B).


Finally after withdrawal of the insertion needle which in this embodiment is attached to the slidable member (32) in the injector device, it is shown in FIGS. 35E and 36E how the pivoting member (36) is placed in a position where it is embracing the needle thereby protecting the surroundings from getting stung. In order to get into this position the pivoting arm (36) is turned approximately 180° from the position in FIGS. 35D and 36D, and the angle w between the main plane of the injector device and the pivoting arm (36) is approximately 90°.

Claims
  • 1. An infusion set comprising an infusion part for insertion into a patient and a connector for connecting the infusion part with a medical device through a tube, the connector being axially displaceable relative to the infusion part, the infusion part comprising: an adhesive support;a base connected to the adhesive support, the base part including a first set of guides and at least two retention devices for releasably locking the connector to the infusion part, said retention devices extending upwardly from an upper surface of the base;a first cannula extending from said base and being in fluid communication with a cavity, said cavity being adapted to receive a second cannula extending from the connector, wherein said second cannula is in fluid communication with the tube; andthe connector comprising: a second set of guides adapted to fit with the first set of guides and at least two arms adapted to fit with the retention devices, the arms are movable in a laterally inward direction, in a laterally outward direction and in an upward direction away from the base such that movement of the arms in either the laterally inward direction, the laterally outward direction or the upward direction allows disengagement of the arms from the retention devices.
  • 2. An infusion set according to claim 1, wherein the connector is symmetrical relative to a main plane of the connector and relative to a plane perpendicular to the main plane and parallel to the central axis.
  • 3. An infusion set according to claim 1 wherein each arm is flexibly connected to the second set of guides in order for the arms to be able to move in the direction perpendicular to the base.
  • 4. An infusion set according to claim 3, wherein the connection between each arm and the second set of guides comprises at least one groove.
  • 5. An infusion set according to claim 1, wherein the retention devices are flexibly connected to the base.
  • 6. An infusion set according to claim 5, wherein the base comprises at least two flaps on which the retention devices are positioned.
  • 7. An infusion set according to claim 1, wherein the first cannula passes through the adhesive support.
  • 8. An infusion set according to claim 1, wherein the adhesive support is a plaster.
  • 9. An infusion set according to claim 1, wherein the infusion part and the connector comprise two different plastics materials.
  • 10. An infusion set according to claim 1, wherein the visual tone of the connector and the base of the infusion part are different.
  • 11. An infusion set according to claim 1, wherein each of the retention devices comprises a step.
  • 12. An infusion set according to claim 1, wherein each of the retention devices comprises a triangular shape.
  • 13. An infusion set according to claim 1, wherein the tube is fastened to the connector by glue.
  • 14. An infusion set according to claim 1, wherein the medical device is an insulin pump.
  • 15. An infusion set according to claim 1, wherein the first cannula comprises a thermoplastic elastomer (TPE).
  • 16. An infusion set according to claim 15, wherein the thermoplastic elastomer is selected from the group consisting of polyester ethers, ECDEL, styrene based TPE, olefin based TPE, urethane based TPE, ester based TPE, amid based TPE, polyolefins and silicone rubbers.
  • 17. An infusion set according to claim 1, wherein the infusion part the connector, or both comprise polypropylene.
  • 18. An infusion set according to claim 1, wherein, the second cannula extends from a central part of the connector and the second cannula is recessed relative to a front portion of the central part and at least one of the first set of guides comprises at least two stabilizing fins.
  • 19. An infusion set according to claim 1, further comprising an injector device for the subcutaneous introduction of the first cannula of the infusion part into the skin of a patient.
  • 20. An infusion set according to claim 19, wherein the injector device comprises a housing, a back and longitudinally extending guide, a slidable member which is longitudinally slidable within the housing, a needle for insertion in the cavity of the first cannula, a spring located between the back of the housing and the longitudinally slidable member, locking members for maintaining the spring in a compressed state and release members for disengaging the locking members, and a pivoting member pivotable from a position allowing for insertion of the needle into a position wherein the pivoting member embraces the needle.
  • 21. The infusion set according to claim 1, wherein said cavity is covered with a membrane.
  • 22. The infusion set of claim 1 wherein the second cannula is received into the cavity in a horizontal direction parallel to a main plane of the base part.
  • 23. An infusion set comprising an infusion part and a connector releasably connectable to the infusion part, the infusion part comprising: a base having a lower surface and an upper surface, the upper surface comprising a first guide and a releasable locking member extending upwardly from the upper surface for releasably connecting the infusion part to the connector; anda first cannula extending outwardly from the base,the connector comprising: a second guide adapted to fit with the first guide;an arm operably connected to the second guide for releasably interlocking with the locking member, the arm is movable in a laterally inward direction, in a laterally outward direction and in an upward direction away from the base such that movement of the arm in either the laterally inward direction, the laterally outward direction or the upward direction allows disengagement of the arm from the releasable locking member; anda second cannula extending outwardly from the connector and adapted for reception at least partially within a cavity formed in the base;wherein the first cannula and the second cannula are fluidly connectable.
  • 24. The infusion set of claim 23, wherein the infusion set further comprises an adhesive layer connected to the lower surface of the base.
  • 25. The infusion set of claim 23, comprising a membrane covering an opening of the cavity.
  • 26. The infusion set of claim 23, wherein the base comprises a pair of first guides and a pair of locking members adapted to connect with a pair of second guides and a pair of arms on the connector.
  • 27. The infusion set of claim 23, wherein the connector further comprises tubing fluidly connectable between the second cannula and a medication source.
Priority Claims (1)
Number Date Country Kind
2004 00493 Mar 2004 DK national
Parent Case Info

This application is a continuation of International Application No. PCT/DK2005/000189, filed Mar. 21, 2005, which claims the benefit of U.S. Provisional Application No. 60/556,863, filed Mar. 26, 2004 and Danish Patent Application No. PA 200400493, filed Mar. 26, 2004, these references are incorporated herein in their entirety.

US Referenced Citations (547)
Number Name Date Kind
1592462 MacGregor Jul 1926 A
2047010 Dickinson Jul 1936 A
2295849 Kayden Sep 1942 A
2690529 Lindblad Sep 1954 A
2936141 Rapata May 1960 A
2972779 Cowley Feb 1961 A
3059802 Mitchell Oct 1962 A
3074541 Roehr Jan 1963 A
3221739 Rosenthal Dec 1965 A
3221740 Rosenthal Dec 1965 A
3306291 Burke Feb 1967 A
3485352 Pilger Dec 1969 A
3509879 Bathish et al. May 1970 A
3519158 Anderson Jul 1970 A
3545286 Stenstrom Dec 1970 A
3547119 Hall et al. Dec 1970 A
3610240 Harautuneian Oct 1971 A
3670727 Reiterman Jun 1972 A
3783895 Weichselbaum Jan 1974 A
3788374 Saijo Jan 1974 A
3810469 Hurschman May 1974 A
3840011 Wright Oct 1974 A
3893448 Brantigan Jul 1975 A
3937219 Karakashian Feb 1976 A
3986507 Watt Oct 1976 A
3986508 Barrington Oct 1976 A
3995518 Spiroff Dec 1976 A
4022205 Tenczar May 1977 A
4188950 Wardlaw Feb 1980 A
4201406 Dennehey et al. May 1980 A
4227528 Wardlaw Oct 1980 A
4259276 Rawlings Mar 1981 A
4267836 Whitney et al. May 1981 A
4296786 Brignola Oct 1981 A
4315505 Crandall et al. Feb 1982 A
4333455 Bodicky Jun 1982 A
4334551 Pfister Jun 1982 A
D267199 Koenig Dec 1982 S
4378015 Wardlaw Mar 1983 A
4415393 Grimes Nov 1983 A
4417886 Frankhouser et al. Nov 1983 A
4464178 Dalton Aug 1984 A
4473369 Lueders et al. Sep 1984 A
4484910 Sarnoff et al. Nov 1984 A
4500312 McFarlane Feb 1985 A
4525157 Vaillancourt Jun 1985 A
4530695 Phillips et al. Jul 1985 A
4531937 Yates Jul 1985 A
4563177 Kamen Jan 1986 A
4610469 Wolff-Mooij Sep 1986 A
4617019 Fecht Oct 1986 A
4713059 Bickelhaupt et al. Dec 1987 A
4734092 Millerd Mar 1988 A
4755173 Konopka et al. Jul 1988 A
4758020 Boyd Jul 1988 A
4800629 Ikeda Jan 1989 A
4817603 Turner et al. Apr 1989 A
RE32922 Levin et al. May 1989 E
4838871 Luther Jun 1989 A
4840613 Balbierz Jun 1989 A
4850974 Bickelhaupt et al. Jul 1989 A
4850996 Cree Jul 1989 A
4863016 Fong et al. Sep 1989 A
4878897 Katzin Nov 1989 A
4890608 Steer Jan 1990 A
4894054 Miskinyar Jan 1990 A
4895570 Larkin Jan 1990 A
4917669 Bonaldo Apr 1990 A
4935010 Cox et al. Jun 1990 A
4950163 Zimble Aug 1990 A
4950252 Luther et al. Aug 1990 A
4978338 Melsky et al. Dec 1990 A
4982842 Hollister Jan 1991 A
4986817 Code Jan 1991 A
4994042 Vadher Feb 1991 A
4994045 Ranford Feb 1991 A
5011475 Olson Apr 1991 A
5020665 Bruno Jun 1991 A
5024662 Menes et al. Jun 1991 A
5067496 Eisele Nov 1991 A
5092853 Couvertier, II Mar 1992 A
5098389 Cappucci Mar 1992 A
5112313 Sallee May 1992 A
5116319 Van den Haak May 1992 A
5116325 Paterson May 1992 A
5121751 Panalletta Jun 1992 A
5129884 Dysarz Jul 1992 A
5135502 Koenig, Jr. et al. Aug 1992 A
5137516 Rand et al. Aug 1992 A
5137524 Lynn et al. Aug 1992 A
5141496 Dalto et al. Aug 1992 A
5147375 Sullivan et al. Sep 1992 A
5163915 Holleron Nov 1992 A
5172808 Bruno Dec 1992 A
5176643 Kramer et al. Jan 1993 A
5176650 Haining Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5186712 Kelso et al. Feb 1993 A
5188611 Orgain Feb 1993 A
RE34223 Bonaldo Apr 1993 E
5205820 Kriesel Apr 1993 A
5222947 D'Amico Jun 1993 A
5232454 Hollister Aug 1993 A
5248301 Koenig et al. Sep 1993 A
5256149 Banik et al. Oct 1993 A
5256152 Marks Oct 1993 A
5257980 Van Antwerp et al. Nov 1993 A
5267963 Bachynsky Dec 1993 A
5269799 Daniel Dec 1993 A
5271744 Kramer et al. Dec 1993 A
5279579 D'Amico Jan 1994 A
5279591 Simon Jan 1994 A
5282793 Larson Feb 1994 A
5300030 Crossman et al. Apr 1994 A
5312359 Wallace May 1994 A
5312369 Arcusin et al. May 1994 A
5316246 Scott et al. May 1994 A
5324302 Crouse Jun 1994 A
5342319 Watson et al. Aug 1994 A
5342324 Tucker Aug 1994 A
5350392 Purcell et al. Sep 1994 A
5354280 Haber et al. Oct 1994 A
5366469 Steg et al. Nov 1994 A
5372592 Gambale Dec 1994 A
5372787 Ritter Dec 1994 A
5376082 Phelps Dec 1994 A
5379895 Foslien Jan 1995 A
5380067 Turvill et al. Jan 1995 A
5384174 Ward et al. Jan 1995 A
5387197 Smith et al. Feb 1995 A
5388931 Carlson Feb 1995 A
5390669 Stuart et al. Feb 1995 A
5391151 Wilmot Feb 1995 A
5403288 Stanners Apr 1995 A
5405332 Opalek Apr 1995 A
5429607 McPhee Jul 1995 A
5429613 D'Amico Jul 1995 A
5433307 Jeppe Jul 1995 A
5439473 Jorgensen Aug 1995 A
D362718 Deily et al. Sep 1995 S
5449349 Sallee et al. Sep 1995 A
5451210 Kramer et al. Sep 1995 A
5487506 Drummond et al. Jan 1996 A
5490841 Landis Feb 1996 A
5492313 Pan et al. Feb 1996 A
5501675 Erskine Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5507730 Haber et al. Apr 1996 A
5514117 Lynn May 1996 A
5519167 Kunimoto et al. May 1996 A
5520654 Wahlberg May 1996 A
5522803 Teissen-Simony Jun 1996 A
5527287 Miskinyar et al. Jun 1996 A
5533974 Gaba Jul 1996 A
5540709 Ramel Jul 1996 A
5545143 Fischell Aug 1996 A
5545152 Funderburk et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554130 McDonald et al. Sep 1996 A
5558650 McPhee Sep 1996 A
5562629 Haughton et al. Oct 1996 A
5562636 Utterberg Oct 1996 A
5573510 Isaacson Nov 1996 A
5575777 Cover et al. Nov 1996 A
5584813 Livingston et al. Dec 1996 A
5586553 Halili Dec 1996 A
5591188 Waisman Jan 1997 A
5599309 Marshall et al. Feb 1997 A
5599315 McPhee Feb 1997 A
5599318 Sweeney et al. Feb 1997 A
5628765 Morita May 1997 A
5643214 Marshall Jul 1997 A
5643216 White Jul 1997 A
5643220 Cosme Jul 1997 A
5662617 Odell et al. Sep 1997 A
5665071 Wyrick Sep 1997 A
5665075 Gyure et al. Sep 1997 A
5676156 Yoon Oct 1997 A
5681323 Arick Oct 1997 A
5695476 Harris Dec 1997 A
5697907 Gaba Dec 1997 A
5700250 Erskine Dec 1997 A
5702371 Bierman Dec 1997 A
5704920 Gyure Jan 1998 A
5709516 Peterson et al. Jan 1998 A
5714225 Hansen et al. Feb 1998 A
5738641 Watson et al. Apr 1998 A
5741288 Rife Apr 1998 A
5752923 Terwilliger May 1998 A
5807316 Teeple Sep 1998 A
5807348 Zinger et al. Sep 1998 A
5810835 Ryan et al. Sep 1998 A
5817058 Shaw Oct 1998 A
5820598 Gazza et al. Oct 1998 A
5827236 Takahashi Oct 1998 A
5833666 Davis et al. Nov 1998 A
D402538 Wagter et al. Dec 1998 S
5843001 Goldenberg Dec 1998 A
5848990 Cirelli et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5865806 Howell Feb 1999 A
5873540 Hardin Feb 1999 A
5899886 Cosme May 1999 A
5911705 Howell Jun 1999 A
5913846 Szabo Jun 1999 A
5915640 Wagter et al. Jun 1999 A
5916199 Miles Jun 1999 A
5919167 Mulhauser et al. Jul 1999 A
5919170 Woessner Jul 1999 A
5925032 Clements Jul 1999 A
5935109 Donnan Aug 1999 A
5947931 Bierman Sep 1999 A
5947935 Rhinehart et al. Sep 1999 A
5951523 Osterlind et al. Sep 1999 A
5954643 VanAntwerp et al. Sep 1999 A
5957892 Thorne Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5975120 Novosel Nov 1999 A
5980488 Thorne Nov 1999 A
5980506 Mathiasen Nov 1999 A
5984224 Yang Nov 1999 A
5984897 Petersen et al. Nov 1999 A
5992787 Burke Nov 1999 A
D417733 Howell et al. Dec 1999 S
6017328 Fischell et al. Jan 2000 A
6017598 Kreischer et al. Jan 2000 A
D421119 Musgrave et al. Feb 2000 S
6024727 Thorne et al. Feb 2000 A
6039629 Mitchell Mar 2000 A
6042570 Bell et al. Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6045534 Jacobsen et al. Apr 2000 A
6050976 Thorne et al. Apr 2000 A
6053893 Bucher Apr 2000 A
6053930 Ruppert Apr 2000 A
6056718 Funderburk et al. May 2000 A
6056726 Isaacson May 2000 A
6074369 Sage et al. Jun 2000 A
6074371 Fischell Jun 2000 A
6077244 Botich et al. Jun 2000 A
6079432 Paradis Jun 2000 A
6086008 Gray et al. Jul 2000 A
6086575 Mejslov Jul 2000 A
6090068 Chanut Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6093179 O'Hara et al. Jul 2000 A
6099503 Stradella Aug 2000 A
6105218 Reekie Aug 2000 A
6106498 Friedli et al. Aug 2000 A
6120482 Szabo Sep 2000 A
6123690 Mejslov Sep 2000 A
6132755 Eicher et al. Oct 2000 A
6139534 Niedospial, Jr. Oct 2000 A
6159181 Crossman et al. Dec 2000 A
6183464 Sharp et al. Feb 2001 B1
6191338 Haller Feb 2001 B1
6193694 Bell et al. Feb 2001 B1
6210420 Mauze et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6221058 Kao et al. Apr 2001 B1
6248093 Moberg Jun 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302866 Marggi Oct 2001 B1
6319232 Kashmer Nov 2001 B1
6322535 Hitchins et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6334856 Allen et al. Jan 2002 B1
6355021 Nielsen et al. Mar 2002 B1
6379335 Rigon et al. Apr 2002 B1
D456692 Epstein May 2002 S
6387076 Van Landuyt May 2002 B1
6387078 Gillespie, III May 2002 B1
6405876 Seshimoto et al. Jun 2002 B1
6440096 Lastovich et al. Aug 2002 B1
6447482 Rønborg et al. Sep 2002 B1
6450992 Cassidy, Jr. Sep 2002 B1
6485461 Mason et al. Nov 2002 B1
6488663 Steg Dec 2002 B1
6503222 Lo Jan 2003 B2
6517517 Farrugia et al. Feb 2003 B1
6520938 Funderburk et al. Feb 2003 B1
D472316 Douglas et al. Mar 2003 S
D472630 Douglas et al. Apr 2003 S
6572586 Wojcik Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6582397 Alesi et al. Jun 2003 B2
6595962 Perthu Jul 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6607511 Halseth et al. Aug 2003 B2
6613064 Rutynowski et al. Sep 2003 B2
6620133 Steck Sep 2003 B1
6620136 Pressly, Sr. et al. Sep 2003 B1
6620140 Metzger Sep 2003 B1
6629949 Douglas Oct 2003 B1
6645181 Lavi et al. Nov 2003 B1
6645182 Szabo Nov 2003 B1
6659982 Douglas et al. Dec 2003 B2
6685674 Douglas et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6702779 Connelly et al. Mar 2004 B2
6726649 Swenson et al. Apr 2004 B2
6736797 Larsen et al. May 2004 B1
6749587 Flaherty Jun 2004 B2
6749589 Douglas et al. Jun 2004 B1
6755805 Reid Jun 2004 B1
6776775 Mohammad Aug 2004 B1
6790199 Gianakos Sep 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6808506 Lastovich et al. Oct 2004 B2
6811545 Vaillancourt Nov 2004 B2
6814720 Olsen et al. Nov 2004 B2
6824530 Wagner et al. Nov 2004 B2
6824531 Zecha, Jr. et al. Nov 2004 B1
6830562 Mogensen et al. Dec 2004 B2
6837877 Zurcher Jan 2005 B2
6837878 Smutney et al. Jan 2005 B2
6840922 Nielsen et al. Jan 2005 B2
6880701 Bergeron et al. Apr 2005 B2
6916017 Noe Jul 2005 B2
6923791 Douglas Aug 2005 B2
6926694 Marano-Ford et al. Aug 2005 B2
6939331 Ohshima Sep 2005 B2
6949084 Marggi et al. Sep 2005 B2
6959812 Reif et al. Nov 2005 B2
6960193 Rosenberg Nov 2005 B2
6979316 Rubin et al. Dec 2005 B1
6991619 Marano-Ford et al. Jan 2006 B2
6991620 Marano-Ford et al. Jan 2006 B2
6994213 Giard et al. Feb 2006 B2
6997907 Safabash et al. Feb 2006 B2
7014625 Bengtsson Mar 2006 B2
7018344 Bressler et al. Mar 2006 B2
7022108 Marano-Ford et al. Apr 2006 B2
7047070 Wilkenson et al. May 2006 B2
7052483 Wojcik May 2006 B2
7055713 Rea et al. Jun 2006 B2
7056302 Douglas Jun 2006 B2
7070580 Nielsen Jul 2006 B2
7074208 Pajunk et al. Jul 2006 B2
D526409 Nielsen et al. Aug 2006 S
7083592 Lastovich et al. Aug 2006 B2
7083597 Lynch et al. Aug 2006 B2
7097631 Trautman et al. Aug 2006 B2
7109878 Mann et al. Sep 2006 B2
7115108 Wilkenson et al. Oct 2006 B2
7115112 Mogensen et al. Oct 2006 B2
7141023 Diermann et al. Nov 2006 B2
7147623 Mathiasen Dec 2006 B2
7186236 Gibson et al. Mar 2007 B2
7211068 Douglas May 2007 B2
7214207 Lynch et al. May 2007 B2
7214215 Heinzerling et al. May 2007 B2
7250037 Shermer et al. Jul 2007 B2
7258680 Mogensen et al. Aug 2007 B2
D554253 Kornerup Oct 2007 S
7303543 Maule et al. Dec 2007 B1
7309326 Fangrow, Jr. Dec 2007 B2
7407491 Fangrow, Jr. Aug 2008 B2
7407493 Cane′ Aug 2008 B2
7431876 Mejlhede et al. Oct 2008 B2
7441655 Hoftman Oct 2008 B1
7520867 Bowman et al. Apr 2009 B2
7569262 Szabo et al. Aug 2009 B2
7648494 Kornerup et al. Jan 2010 B2
7766867 Lynch et al. Aug 2010 B2
20010004970 Hollister et al. Jun 2001 A1
20010016714 Bell et al. Aug 2001 A1
20010021827 Ferguson et al. Sep 2001 A1
20010039387 Rutynowski et al. Nov 2001 A1
20010039401 Ferguson et al. Nov 2001 A1
20010041875 Higuchi et al. Nov 2001 A1
20010049496 Kirchhofer Dec 2001 A1
20010053889 Marggi et al. Dec 2001 A1
20010056284 Purcell et al. Dec 2001 A1
20020022798 Connelly Feb 2002 A1
20020022855 Bobroff et al. Feb 2002 A1
20020026152 Bierman Feb 2002 A1
20020055711 Lavi et al. May 2002 A1
20020068904 Pluth et al. Jun 2002 A1
20020072720 Hague et al. Jun 2002 A1
20020074345 Schneider et al. Jun 2002 A1
20020077599 Wojcik Jun 2002 A1
20020082543 Park et al. Jun 2002 A1
20020107489 Lee Aug 2002 A1
20020111581 Sasso Aug 2002 A1
20020145073 Swanson et al. Oct 2002 A1
20020156424 Suzuki et al. Oct 2002 A1
20020156427 Suzuki et al. Oct 2002 A1
20020161322 Utterberg et al. Oct 2002 A1
20020161332 Ramey Oct 2002 A1
20020161386 Halseth et al. Oct 2002 A1
20020165493 Bierman Nov 2002 A1
20020169419 Steg Nov 2002 A1
20020173748 McConnell et al. Nov 2002 A1
20020173769 Gray et al. Nov 2002 A1
20020183688 Lastovich et al. Dec 2002 A1
20020189688 Roorda Dec 2002 A1
20020193737 Popovsky Dec 2002 A1
20020193744 Alesi et al. Dec 2002 A1
20030014018 Giambattista et al. Jan 2003 A1
20030060781 Mogensen et al. Mar 2003 A1
20030069548 Connelly et al. Apr 2003 A1
20030088238 Poulsen et al. May 2003 A1
20030105430 Lavi et al. Jun 2003 A1
20030109829 Mogensen et al. Jun 2003 A1
20030125669 Safabash et al. Jul 2003 A1
20030125678 Swenson et al. Jul 2003 A1
20030130619 Safabash et al. Jul 2003 A1
20030139704 Lin Jul 2003 A1
20030158520 Safabash et al. Aug 2003 A1
20030176843 Wilkinson Sep 2003 A1
20030176852 Lynch et al. Sep 2003 A1
20030181863 Ackley et al. Sep 2003 A1
20030181868 Swenson Sep 2003 A1
20030181873 Swenson Sep 2003 A1
20030181874 Bressler et al. Sep 2003 A1
20030187394 Wilkinson et al. Oct 2003 A1
20030187395 Wilkinson et al. Oct 2003 A1
20030199823 Bobroff et al. Oct 2003 A1
20030216686 Lynch et al. Nov 2003 A1
20030220610 Lastovich et al. Nov 2003 A1
20030225373 Bobroff et al. Dec 2003 A1
20030225374 Mathiasen Dec 2003 A1
20030229308 Tsals et al. Dec 2003 A1
20030229316 Hwang et al. Dec 2003 A1
20040002682 Kovelman et al. Jan 2004 A1
20040006316 Patton Jan 2004 A1
20040026840 Eckel et al. Feb 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040049159 Barrus et al. Mar 2004 A1
20040059316 Smedegaard Mar 2004 A1
20040068231 Blondeau Apr 2004 A1
20040069044 Lavi et al. Apr 2004 A1
20040087913 Rogers et al. May 2004 A1
20040092875 Kochamba May 2004 A1
20040111068 Swenson Jun 2004 A1
20040112781 Hofverberg et al. Jun 2004 A1
20040116865 Bengtsson Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040138612 Shermer et al. Jul 2004 A1
20040138620 Douglas et al. Jul 2004 A1
20040143216 Douglas et al. Jul 2004 A1
20040143218 Das Jul 2004 A1
20040158202 Jensen Aug 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040162518 Connelly et al. Aug 2004 A1
20040171989 Horner et al. Sep 2004 A1
20040178098 Swenson et al. Sep 2004 A1
20040186446 Ohshima Sep 2004 A1
20040193143 Sauer Sep 2004 A1
20040199123 Nielsen Oct 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204690 Yashiro et al. Oct 2004 A1
20040215151 Marshall et al. Oct 2004 A1
20040220528 Garcia, Jr. Nov 2004 A1
20040236284 Hoste et al. Nov 2004 A1
20040238392 Peterson et al. Dec 2004 A1
20040243065 McConnell et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040260235 Douglas Dec 2004 A1
20040260250 Harris et al. Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050038378 Lastovich et al. Feb 2005 A1
20050043687 Mogensen et al. Feb 2005 A1
20050049571 Lastovich et al. Mar 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050075606 Botich et al. Apr 2005 A1
20050080386 Reid Apr 2005 A1
20050101910 Bowman et al. May 2005 A1
20050101912 Faust et al. May 2005 A1
20050101932 Cote et al. May 2005 A1
20050101933 Marrs et al. May 2005 A1
20050107743 Fangrow, Jr. May 2005 A1
20050113761 Faust et al. May 2005 A1
20050119611 Marano-Ford et al. Jun 2005 A1
20050119619 Haining Jun 2005 A1
20050119637 Lundgren et al. Jun 2005 A1
20050124936 Mogensen et al. Jun 2005 A1
20050131347 Marano-Ford et al. Jun 2005 A1
20050159709 Wilkinson Jul 2005 A1
20050159714 Gibson Jul 2005 A1
20050165382 Fulford Jul 2005 A1
20050192560 Walls et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050215979 Kornerup et al. Sep 2005 A1
20050240154 Mogensen et al. Oct 2005 A1
20050251098 Wyss et al. Nov 2005 A1
20050256456 Marano-Ford et al. Nov 2005 A1
20050261629 Marano-Ford et al. Nov 2005 A1
20050277892 Chen Dec 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060015063 Butikofer et al. Jan 2006 A1
20060015076 Heinzerling et al. Jan 2006 A1
20060030815 Csincsura et al. Feb 2006 A1
20060036214 Mogensen et al. Feb 2006 A1
20060041224 Jensen Feb 2006 A1
20060069351 Safabash et al. Mar 2006 A9
20060069382 Pedersen Mar 2006 A1
20060069383 Bogaerts et al. Mar 2006 A1
20060095003 Marano-Ford et al. May 2006 A1
20060095014 Ethelfeld May 2006 A1
20060106346 Sullivan et al. May 2006 A1
20060129123 Wojcik Jun 2006 A1
20060135908 Liniger et al. Jun 2006 A1
20060135913 Ethelfeld Jun 2006 A1
20060142698 Ethelfeld Jun 2006 A1
20060161108 Mogensen et al. Jul 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060173413 Fan Aug 2006 A1
20060184104 Cheney, II et al. Aug 2006 A1
20060184140 Okiyama Aug 2006 A1
20060200073 Radmer et al. Sep 2006 A1
20060241551 Lynch et al. Oct 2006 A1
20060247553 Diermann et al. Nov 2006 A1
20060247574 Maule et al. Nov 2006 A1
20060253085 Geismar et al. Nov 2006 A1
20060253086 Moberg et al. Nov 2006 A1
20060264835 Nielsen et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20070005017 Alchas et al. Jan 2007 A1
20070016129 Liniger et al. Jan 2007 A1
20070016159 Sparholt et al. Jan 2007 A1
20070021729 Mogensen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070049870 Gray et al. Mar 2007 A1
20070066955 Sparholt et al. Mar 2007 A1
20070088271 Richards et al. Apr 2007 A1
20070093754 Mogensen Apr 2007 A1
20070104596 Preuthun et al. May 2007 A1
20070112301 Preuthun et al. May 2007 A1
20070112303 Liniger May 2007 A1
20070129688 Scheurer et al. Jun 2007 A1
20070173767 Lynch et al. Jul 2007 A1
20070179444 Causey et al. Aug 2007 A1
20070185441 Fangrow, Jr. Aug 2007 A1
20070191772 Wojcik Aug 2007 A1
20070191773 Wojcik Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070213673 Douglas Sep 2007 A1
20070244448 Lastovich et al. Oct 2007 A1
20080312601 Cane Dec 2008 A1
20100004597 Gyrn et al. Jan 2010 A1
20100137829 Nielsen et al. Jun 2010 A1
20100228226 Nielsen Sep 2010 A1
Foreign Referenced Citations (173)
Number Date Country
4 342 329 Jun 1994 DE
196 31 921 Mar 1997 DE
299 05 072 Sep 1999 DE
101 17 285 Nov 2002 DE
203 20 207 Nov 2004 DE
EP 1 360 970 Nov 2003 DK
EP 1 475 113 Nov 2004 DK
0 117 632 Sep 1984 EP
0 239 244 Feb 1987 EP
0272530 Jun 1988 EP
0 451 040 Oct 1991 EP
0 544 837 Jun 1993 EP
0 651 662 May 1995 EP
0652027 May 1995 EP
0 657 184 Jun 1995 EP
0 714 631 Jun 1996 EP
0 744 183 Nov 1996 EP
0 747 006 Dec 1996 EP
0799626 Oct 1997 EP
0 688 232 Dec 1998 EP
0937475 Aug 1999 EP
0 956 879 Nov 1999 EP
0 615 768 Dec 1999 EP
1 086 718 Mar 2001 EP
1 125 593 Aug 2001 EP
0 775 501 Jun 2002 EP
1 329 233 Jul 2003 EP
1350537 Oct 2003 EP
1 380 315 Jan 2004 EP
1 407 747 Apr 2004 EP
1407793 Apr 2004 EP
1 421 968 May 2004 EP
1495775 Jan 2005 EP
1502613 Feb 2005 EP
1525873 Apr 2005 EP
1527792 May 2005 EP
1616594 Jan 2006 EP
1704889 Sep 2006 EP
1719537 Nov 2006 EP
1762259 Mar 2007 EP
1764125 Mar 2007 EP
1177802 Sep 2004 FK
2725902 Oct 1994 FR
2 752 164 Feb 1998 FR
478803 Jan 1938 GB
906574 Sep 1962 GB
2 088 215 Jun 1982 GB
2 230 702 Oct 1990 GB
2 423 267 Aug 2006 GB
A-03-191965 Aug 1991 JP
7051251 Nov 1995 JP
A-08-187286 Jul 1996 JP
A-10-179734 Jul 1998 JP
2002-028246 Jan 2002 JP
WO 8101795 Jul 1981 WO
WO 8203558 Oct 1982 WO
WO 9204062 Mar 1992 WO
WO 9305840 Apr 1993 WO
WO 9311709 Jun 1993 WO
WO 9420160 Sep 1994 WO
WO 9620021 Jul 1996 WO
WO 96032981 Oct 1996 WO
WO 9826835 Jun 1998 WO
WO 9833549 Aug 1998 WO
WO 9858693 Dec 1998 WO
WO 9907435 Feb 1999 WO
WO 9933504 Jul 1999 WO
WO 0002614 Jan 2000 WO
WO 0003757 Jan 2000 WO
WO 0044324 Aug 2000 WO
WO 0130419 May 2001 WO
WO 0168180 Sep 2001 WO
WO 0172353 Oct 2001 WO
WO 0176684 Oct 2001 WO
WO 0193926 Dec 2001 WO
WO 0202165 Jan 2002 WO
WO 0207804 Jan 2002 WO
WO 0240083 May 2002 WO
WO 02053220 Jul 2002 WO
WO 02081012 Oct 2002 WO
WO 02081013 Oct 2002 WO
WO 02083206 Oct 2002 WO
WO 02094352 Nov 2002 WO
WO 02100457 Dec 2002 WO
WO 02102442 Dec 2002 WO
WO 02068014 Jan 2003 WO
WO 03015860 Feb 2003 WO
WO 03026728 Apr 2003 WO
WO 03068305 Aug 2003 WO
WO 03075980 Sep 2003 WO
WO 03095003 Nov 2003 WO
WO 2004012796 Feb 2004 WO
WO 2004029457 Apr 2004 WO
WO 2004030726 Apr 2004 WO
WO 2004037325 May 2004 WO
WO 2004054644 Jul 2004 WO
WO 2004056412 Jul 2004 WO
WO 2004064593 Aug 2004 WO
WO 2004071308 Aug 2004 WO
WO 2004087240 Oct 2004 WO
WO 2004098683 Nov 2004 WO
WO 2004101016 Nov 2004 WO
WO 2004101071 Nov 2004 WO
WO 2004110527 Dec 2004 WO
WO 2005002649 Jan 2005 WO
WO 2005004973 Jan 2005 WO
WO 2005018703 Mar 2005 WO
WO 2005037184 Apr 2005 WO
WO 2005037350 Apr 2005 WO
WO 2005039673 May 2005 WO
WO 2005046780 May 2005 WO
WO 2005065748 Jul 2005 WO
WO 2005068006 Jul 2005 WO
WO 2005072795 Aug 2005 WO
WO 2005094920 Oct 2005 WO
WO 2005118055 Dec 2005 WO
WO 2006003130 Jan 2006 WO
WO 2006015507 Feb 2006 WO
WO 2006015600 Feb 2006 WO
WO 2006024650 Mar 2006 WO
WO 2006032689 Mar 2006 WO
WO 2006032692 Mar 2006 WO
WO 2006061027 Jun 2006 WO
WO 2006061354 Jun 2006 WO
WO 2006062912 Jun 2006 WO
WO 2006075016 Jul 2006 WO
WO 2006077262 Jul 2006 WO
WO 2006077263 Jul 2006 WO
WO 2006089958 Aug 2006 WO
WO 2006097111 Sep 2006 WO
WO 2006108775 Oct 2006 WO
WO 2006120253 Nov 2006 WO
WO 2006121921 Nov 2006 WO
WO 2006122048 Nov 2006 WO
WO 2007000162 Jan 2007 WO
WO 2007002523 Jan 2007 WO
WO 200702009 Feb 2007 WO
WO 2007065944 Jun 2007 WO
WO 2007071255 Jun 2007 WO
WO 2007071258 Jun 2007 WO
WO 2007093051 Aug 2007 WO
WO 2007093182 Aug 2007 WO
WO 2007122207 Nov 2007 WO
WO 2007140631 Dec 2007 WO
WO 2007140783 Dec 2007 WO
WO 2007140785 Dec 2007 WO
WO 2007141210 Dec 2007 WO
WO 2008014791 Feb 2008 WO
WO 2008014792 Feb 2008 WO
WO 2008048631 Apr 2008 WO
WO 2008052545 May 2008 WO
WO 2008092782 Aug 2008 WO
WO 2008092958 Aug 2008 WO
WO 2008092959 Aug 2008 WO
WO 2008135098 Nov 2008 WO
WO 2008148714 Dec 2008 WO
WO 2008155145 Dec 2008 WO
WO 2008155377 Dec 2008 WO
WO 2009004026 Jan 2009 WO
WO 2009007287 Jan 2009 WO
WO 2009010396 Jan 2009 WO
WO 2009010399 Jan 2009 WO
WO 2009098291 Aug 2009 WO
WO 2009098306 Aug 2009 WO
WO 2009101130 Aug 2009 WO
WO 2009101145 Aug 2009 WO
WO 2009103759 Aug 2009 WO
WO 2009106517 Aug 2009 WO
WO 2009144272 Dec 2009 WO
WO 2010003885 Jan 2010 WO
WO 2010003886 Jan 2010 WO
WO 2010034830 Apr 2010 WO
WO 2010072664 Jul 2010 WO
Related Publications (1)
Number Date Country
20080119792 A1 May 2008 US
Provisional Applications (1)
Number Date Country
60556863 Mar 2004 US
Continuations (1)
Number Date Country
Parent PCT/DK2005/000189 Mar 2005 US
Child 10594048 US